The #1 Sensor-based Glucose Monitoring System Used Worldwide1 – easy and accessible

Why sensor-based glucose monitoring leads to better diabetes management

Learn how patients can meet the three goals of the Triangle of Diabetes Care, keep their Time in Range up, and ultimately, improve clinical outcomes and quality of their life.2,3,4

How the FreeStyle Libre 2 ecosystem works together

Explore how the FreeStyle Libre 2 portfolio and digital health solutions connect, to provide you with more insights to better management and outcomes for your diabetes patients.5,6

Scientific Evidence

Explore the studies surrounding Flash Glucose Monitoring and the FreeStyle Libre 2 systems for more details on study design, patient population and study outcomes.

Education, Training and Case Studies 

Discover our library of educational modules, webinars and case studies for your peer to peer discussions.



Please enter a valid email address Please enter the email

By selecting “JOIN & NOTIFY ME”, I agree that:

  1. The information I’ve provided will be used only by Abbott and its contracted third parties to email me helpful information on diabetes and related treatments, products and services, and for marketing and information purposes. 
  2. Abbott will not sell or transfer my name or contact information to any third party for its marketing use.

(*) Required fields

References & Disclaimers

Images are for illustrative purposes only.  Not real patient, data, or healthcare professional.

^ FreeStyle Libre 2 systems are part of the same family of products.

† Finger pricks are required if glucose readings and alarms do not match symptoms or expectations. Alarms are available for FreeStyle Libre 2  sensor users.

1. Data on file, Abbott Diabetes Care. Data based on the number of users worldwide for the FreeStyle Libre 2 systems compared to the number of users for other leading personal use sensor-based glucose monitoring systems.

2. Mark Evans, Zöe Welsh, Sara Ells, Alexander Seibold. “The Impact of Flash Glucose Monitoring on Glycaemic Control as Measured by HbA1c: a Meta-Analysis of Clinical Trials and Real-World Observational Studies.” Diabetes Therapy 11, no. 1 (2020):83–95.

3. Marion Fokkert, Peter van Dijk, Mireille Edens, Eglantine Barents, Jeanine Mollema, Robert Slingerland, Reinhold Gans, Henk Bilo. “Improved Well-Being and Decreased Disease Burden After 1-Year Use of Flash Glucose Monitoring (FLARE-NL4).” BMJ Open Diabetes Research & Care 7, e000809 (2019).

4. Lang J, Jangam S, Dunn T, Hayter G. Expanded real-world use reaffirms strong correlation between scanning frequency of flash glucose monitoring and glucose control [Poster 972]. Diabetes 2019 Jun; 68(Supplement 1).

5. Unger, J., Postgrad Med. (2020):

6. Battelino T, Danne T, Bergenstal RM, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019;42(8):1593-1603.

Cookie Policy

FreeStyle Libre uses cookies to give you the best possible service. By using our website, you consent to the use of cookies. 

Data protection